4.7 Article

Impact of weather and climate change with indoor and outdoor air quality in asthma: A Work Group Report of the AAAAI Environmental Exposure and Respiratory Health Committee

期刊

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
卷 143, 期 5, 页码 1702-1710

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2019.02.018

关键词

Weather; climate; allergy; asthma; pollution; pollen

向作者/读者索取更多资源

Weather and climate change are constant and ever-changing processes that affect allergy and asthma. The purpose of this report is to provide information since the last climate change review with a focus on asthmatic disease. PubMed and Internet searches for topics included climate and weather change, air pollution, particulates, greenhouse gasses, traffic, insect habitat, and mitigation in addition to references contributed by the individual authors. Changes in patterns of outdoor aeroallergens caused by increasing temperatures and amounts of carbon dioxide in the atmosphere are major factors linked to increased duration of pollen seasons, increased pollen production, and possibly increased allergenicity of pollen. Indoor air pollution threats anticipated from climate changes include microbial and mold growth secondary to flooding, resulting in displacement of persons and need for respiratory protection of exposed workers. Air pollution from indoor burning of mosquito repellants is a potential anticipatory result of an increase in habitat regions. Air pollution from fossil fuel burning and traffic-related emissions can alter respiratory defense mechanisms and work synergistically with specific allergens to enhance immunogenicity to worsen asthma in susceptible subjects. Community efforts can significantly reduce air pollution, thereby reducing greenhouse gas emission and improving air quality. The allergist's approach to weather pattern changes should be integrated and anticipatory to protect at-risk patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Allergy

Review of evidence supporting the use of nasal corticosteroid irrigation for chronic rhinosinusitis

Jonathan A. Bernstein, Andrew A. White, Joseph K. Han, David M. Lang, David Elkayam, Fuad M. Baroody

Summary: This study aimed to analyze published reports on the efficacy and safety of corticosteroid irrigation (CSI) in chronic rhinosinusitis (CRS) with nasal polyps and evaluate its clinical implications. CSI is commonly used for the treatment of CRS, but it is not approved by the FDA.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2023)

Review Dermatology

Healthcare Disparities in Atopic Dermatitis in Latin America: A Narrative Review

Jorge Sanchez, Iris-Selva Ale, Maria Valeria Angles, Guillermo Guidos Fogelbach, Angela Marie Jansen, Roberto Takaoka, Arturo Borzutzky

Summary: Atopic dermatitis is a chronic, pruritic skin disease with a complex etiology. In Latin America, the prevalence of AD is high in children and adults. Most patients experience remission in adolescence and adulthood, but there are still a significant number of patients who continue to have symptoms. Access to healthcare services is limited for some patients, leading to healthcare disparities. Recognizing and resolving these disparities is crucial for improving the treatment and quality of life of individuals with AD.

DERMATOLOGY AND THERAPY (2023)

Article Allergy

The One Health approach for allergic diseases and asthma

Marek Jutel, Giselle S. Mosnaim, Jonathan A. Bernstein, Stefano del Giacco, David A. Khan, Kari C. Nadeau, Isabella Pali-Schoell, Maria J. Torres, Magdalena Zemelka-Wiacek, Ioana Agache

Summary: The One Health approach is a collaborative and interdisciplinary strategy that focuses on the interconnections between human, animal, and environmental health. It can advance the management of allergic diseases and asthma by addressing their complex and multifactorial nature. The impacts of allergens, infectious agents, and irritants on allergic diseases and asthma are influenced by environmental health intertwined with animal health. A coordinated response across sectors such as public health, veterinary medicine, and environmental science is needed, along with activities like monitoring and surveillance, targeted interventions, and research on underlying mechanisms.

ALLERGY (2023)

Article Immunology

A focused report on progestogen hypersensitivity

Diti H. H. Patel, Lauren M. M. Fine, Jonathan A. A. Bernstein

Summary: Progestogen Hypersensitivity (PH) is characterized by recurrent cutaneous eruptions and systemic symptoms, caused by increased sensitivity to progestogens. The prevalence of PH is expected to increase due to the widespread use of oral contraceptives and hormonal treatments. A better understanding of the underlying mechanisms and the development of accurate diagnostic tests are needed for improved recognition and management of the condition.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Review Allergy

Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach

Matthew Greenhawt, Timothy E. Dribin, Elissa M. Abrams, Marcus Shaker, Derek K. Chu, David B. K. Golden, Cem Akin, Akterini Anagnostou, Faisal Almuhizi, Waleed Alqurashi, Peter Arkwright, James L. Baldwin, Aleena Banerji, Philippe Begin, Moshe Ben-Shoshan, Jonathan Bernstein, Theresa A. Bingemann, Carsten Bindslev-Jensen, Kim Blumenthal, Aideen Byrne, Julia Cahill, Scott Cameron, Dianne Campbell, Ronna Campbell, Michael Cavender, Edmond S. Chan, Sharon Chinthrajah, Pasquale Comberiati, Jacqueline J. Eastman, Anne K. Ellis, David M. Fleischer, Adam Fox, Pamela A. Frischmeyer-Guerrerio, Remi Gagnon, Lene H. Garvey, Mitchell H. Grayson, Ghislaine Annie Clarisse Isabwe, Nicholas Hartog, David Hendron, Caroline C. Horner, Johnathan O'B Hourihane, Edward Iglesia, Manstein Kan, Blanka Kaplan, Constance H. Katelaris, Harold Kim, John M. Kelso, David A. Khan, David Lang, Dennis Ledford, Michael Levin, Jay A. Lieberman, Richard Loh, Douglas P. Mack, Bruce Mazer, Ketan Mody, Gisele Mosnaim, Daniel Munblit, S. Shahzad Mustafa, Anil Nanda, Richard Nathan, John Oppenheimer, Iris M. Otani, Miguel Park, Ruby Pawankar, Kirsten P. Perrett, Jonny Peter, Elizabeth J. Phillips, Matthieu Picard, Mitchell Pitlick, Allison Ramsey, Trine Holm Rasmussen, Melinda M. Rathkopf, Hari Reddy, Kara Robertson, Pablo Rodriguez del Rio, Stephen Sample, Ajay Sheshadri, Javed Sheik, Sayantani B. Sindher, Jonathan M. Spergel, Cosby A. Stone, David Stukus, Mimi L. K. Tang, James M. Tracy, Paul J. Turner, Timothy K. Vander Leek, Dana V. Wallace, Julie Wang, Susan Wasserman, David Weldon, Anna R. Wolfson, Margitta Worm, Mona-Rita Yacoub

Summary: This guidance provides updates on immediate allergic reactions following COVID-19 vaccines, including recommendations for revaccinating individuals with first-dose allergic reactions and conducting allergy testing. The recommendations were formed by an international panel of experts and are based on recent meta-analyses and diagnostic accuracy studies.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Review Allergy

Scoping review: multiple stakeholders and child asthma management interventions

Samuel Adabla, Laura A. Nabors, Olutosin Sanyaolu, Afolakemi Olaniyan, Jonathan A. Bernstein

Summary: This study reviewed research on interventions aimed at improving asthma management among children by educating parents and other professionals. Stakeholders developed programs that resulted in improvements in asthma symptoms, knowledge of asthma management, perceptions of health care, and decreased emergency health care visits. Successful interventions involved education about asthma management, providing medications, and partnerships with school staff, healthcare teams, and community members.

JOURNAL OF ASTHMA (2023)

Review Allergy

Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Wasuchon Chaichan, Chidchanok Ruengorn, Kednapa Thavorn, Brian Hutton, Jacek C. Szepietowski, Jonathan A. Bernstein, Mati Chuamanochan, Surapon Nochaiwong

Summary: A systematic review and network meta-analysis were conducted to compare the safety profiles of different second-generation H1-antihistamines in patients with chronic urticaria. The study found variations in safety profiles, with mizolastine, emedastine, and cetirizine associated with unfavorable safety profiles.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Article Medicine, General & Internal

Why a Complete Response Is the Treatment Aim in Chronic Spontaneous Urticaria

Jonathan A. Bernstein, Ana Gimenez-Arnau, Marcus Maurer, Petra Staubach, Nathalie Barbier, Eva Hua, Thomas Severin, Pedro A. Laires, Maria-Magdalena Balp

Summary: This study investigated the association between urticaria activity and health-related quality of life. The results showed that chronic spontaneous urticaria significantly impacted the patients' HRQoL. Patients with complete response to treatment had no impairments on health-related quality of life and improved work capacities compared to those with minimal disease activity.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Medicine, Research & Experimental

Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review

Jonathan A. Bernstein, Jean-Pierre Llanos, Gillian Hunter, Neil Martin, Christopher S. Ambrose

Summary: This study describes the reduction of annualized asthma exacerbation rate (AAER) from randomized controlled trials (RCTs) in patients with allergic severe asthma. The study found that the efficacy of biologics varied considerably overall and by baseline blood eosinophil count (BEC), with tezepelumab consistently demonstrating the greatest reduction in AAER across all subgroups.

ADVANCES IN THERAPY (2023)

Article Allergy

Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy

P. J. de Kam, S. Zielen, J. A. Bernstein, U. Berger, M. Berger, M. Cuevas, D. Cypcar, A. Fuhr-Horst, W. A. Greisner, M. Jandl, S. Lassmann, M. Worm, J. Matz, E. Sher, C. Smith, G. C. Steven, R. Moesges, M. H. Shamji, L. DuBuske, F. Borghese, K. Oluwayi, T. Zwingers, M. Seybold, O. Armfield, M. D. Heath, S. J. Hewings, M. F. Kramer, M. A. Skinner

Summary: The study evaluated the efficacy and safety of a modified grass allergen subcutaneous immunotherapy for grass-pollen allergic rhinitis/rhinoconjunctivitis. The results showed clinically relevant and statistically significant improvements in symptom and medication scores, as well as a good safety profile.

ALLERGY (2023)

Editorial Material Allergy

Recall urticaria with infusion of agalsidase beta

Raagini Suresh Yedidi, Jonathan A. Bernstein

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2023)

Review Allergy

An updated review of pediatric autoimmune neuropsychiatric disorders associated with Streptococcus/pediatric acute-onset neuropsychiatric syndrome, also known as idiopathic autoimmune encephalitis: What the allergist should know

Hannah Hardin, Wenhai Shao, Jonathan A. Bernstein

Summary: This article provides an updated review on the diagnosis, management, and treatment of pediatric autoimmune neuropsychiatric disorder associated with streptococcus and pediatric autoimmune neuropsychiatric syndrome, also known as idiopathic autoimmune encephalitis (IAE). The study outlines current knowledge on IAE pathophysiology, clinical manifestations, and epidemiology, as well as diagnostic recommendations and treatment guidelines. The article emphasizes the need for interdisciplinary collaboration and further research to improve the recognition and acceptance of this condition.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2023)

Review Respiratory System

Epithelial alarmins: a new target to treat chronic respiratory diseases

Denislava Nedeva, Krzysztof Kowal, Stefan Mihaicuta, Guillermo Guidos Fogelbach, Paschalis Steiropoulos, Herberto Jose Chong-Neto, Angelica Tiotiu

Summary: This article reviews the role of TSLP, IL-33, IL-25, and HMGB1 in the pathogenesis of asthma, COPD, idiopathic pulmonary fibrosis, and cystic fibrosis. It also summarizes the current evidence on the efficacy of anti-alarmin therapies in chronic respiratory diseases.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2023)

Article Allergy

A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema

Remy S. Petersen, Laura Bordone, Marc A. Riedl, Raffi Tachdjian, Timothy J. Craig, William R. Lumry, Michael E. Manning, Jonathan A. Bernstein, Jason Raasch, Bruce L. Zuraw, Yiwen Deng, Kenneth B. Newman, Veronica J. Alexander, Cindy Lui, Eugene Schneider, Danny M. Cohn

Summary: The 2-year interim results of this phase 2 open-label extension study of donidalorsen in patients with HAE demonstrated no new safety signals. Donidalorsen was well tolerated with durable efficacy, resulting in a 96% reduction in HAE attacks.

ALLERGY (2023)

暂无数据